Wang, Li

VISTA is an immune checkpoint molecule for human T cells

Lines, J. L., Pantazi, E., Mak, J., Sempere, L. F., Wang, L., O'Connell, S., Ceeraz, S., Suriawinata, A. A., Yan, S., Ernstoff, M. S., et al. (2014) · Cancer Research

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 510

Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses

Liu, J., Yuan, Y., Chen, W., Putra, J., Suriawinata, A. A., Schenk, A. D., Miller, H. E., Guleria, I., Barth, R. J., Huang, Y. H., et al. (2015) · Proceedings of the National Academy of Sciences

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 374

VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy

Lines, J. L., Sempere, L. F., Broughton, T., Wang, L., & Noelle, R. (2014) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 236

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors

Roy, D., Gilmour, C., Patnaik, S., & Wang, L. L. (2023) · Frontiers in Immunology

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 53